LIVZON PHARMA (01513.HK) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Dec24

Lizhu Pharmaceutical and XinKangHe BioMed's Lekangqita Injection Receives NMPA Marketing Authorization Application Acceptance

09:36

Dec21

Lizhu Pharmaceutical Factory Obtains Approval for NS-041 Tablet's New Clinical Trial for Depression

07:53

Dec3

Lizhu Pharmaceutical Donates 10 Million HKD to Support Victims of Hong Kong Fire

02:40

Nov7

Lizhu Pharmaceutical repurchased 160,100 A-shares

09:56

Nov3

Lizhu Pharmaceutical Repurchased 164,000 A-shares for 5.9969 Million Yuan

09:50

Oct30

2025 National Medical Insurance Catalog Negotiation Launched

06:19

Schedules & Filings

Schedules

Filings

Oct23

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 3.109 B, Net Income 517.08 M, EPS 0.5788

Aug20

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 3.384 B, Net Income 705.29 M, EPS 0.7878

Jul11

Distribution Plan(CST)

Cash dividend 1.1987 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More